Upcoming Medical Conferences in Bethesda

MedStar Genomic Medicine: Pharmacogenomics 2019 is organized by MedStar Health and will be held on Mar 23, 2019 at Bethesda Marriott, Bethesda, Maryland, United States of America. The target audience for this medical event is primary care providers, family practitioners, oncologists, psychiatrists, cardiologists, physician assistants, nurse practitioners, pharmacists and all other members of the healthcare team interested in pharmacogenomics. This Conference has been approved for a maximum of 9 Interprofessional Continuing Education (IPCE) credits for learning and change. Conference Description: The program aims to provide an overview of genomic medicine and pharmacogenetics, review specialties where advancements in pharmacogenetics can improve the quality of care, and offer perspective from leading experts in how pharmacogenetics can transform clinical practice. Despite patient and clinician interest in genomic medicine, education is often the limiting factor to clinical application. The program will include general concepts necessary for foundational knowledge in genomic medicine. Attendees will be exposed to a variety of use cases for pharmacogenetics (e.g., pain management, psychiatry, cardiology) and molecular tumor profiling in oncology. Case-based discussions will allow practitioners and healthcare professionals to hear and discuss real-world experiences in using pharmacogenetics in the daily practice of medicine. Conference Objectives: • Summarize foundational concepts related to genomic medicine and pharmacogenetics • Identify key resources for the clinical application of pharmacogenetics • Recognize that evidence levels vary between different drug-gene pairs • Identify clinical scenarios where a genetic result can guide therapy • Explain how pharmacogenetic results can be used in prescribing decisions Additional details will be posted as soon as they are available.

Kidney and Bladder Cancers: Updates on Clinical Management 2019 is organized by MedStar Health and will be held on Mar 23, 2019 at Bethesda North Marriott Hotel & Conference Center, Bethesda, Maryland, United States of America. The target audience for this medical event is oncologists, pathologists, radiation oncologists, urologists, residents, fellows, medical students, nurse practitioners, nurses, physician assistants, pharmacists, allied health professionals, and other members of the healthcare team interested in the management of kidney and bladder cancers. This Conference has been approved for a maximum of 7.25 Interprofessional Continuing Education (IPCE) Credits. Conference Description: This biennial, multidisciplinary, one-day conference will provide an update on the clinical management of patients with kidney and bladder (urothelial) cancers. Didactic lectures will present the many recent advances in the treatment of these diseases and their integration into the multidisciplinary management of patients with early stage, high risk, and metastatic disease. Presentations will also discuss emerging controversies and ongoing research aimed at addressing them. Interactive discussions with experts in the field will enhance the learning experience. Conference Objectives: • Discuss current status of adjuvant therapy for patients with high risk kidney cancer. • Analyze treatment options for second line therapy for immune therapy resistant kidney cancer. • Evaluate the role of immune therapy alone and in combination for patients with kidney cancer. • Discuss the current approaches to treatment of patients with non clear cell kidney cancer. • Evaluate the changing role of VEGF therapy in patients with kidney cancer. • Analyze current unresolved clinical management issues and clinical research opportunities. • Evaluate the role of surgery in the management of patients with all stages of kidney cancer • Describe the evaluation and management of BCG refractory non-muscle invasive bladder cancer. • Evaluate molecular advances in urothelial carcinoma that support personalized bladder cancer management strategies. • Describe the evolution of immunotherapy in the treatment of advanced urothelial cancer. • Utilize appropriate multidisciplinary therapy approaches for muscle invasive bladder cancer. • Analyze critical clinical questions in urothelial carcinoma that are being addressed by clinical research. • Recognize drug therapies used in the treatment of clear cell RCC and non clear cell RCC. • Explain the role of cytoreductive nephrectomy in the treatment of RCC. • Recognize toxicities and optimize the management of class-specific side effects of renal cell carcinoma therapies including immunotherapy and VEGFR TKIs. • Utilize multidisciplinary evaluation and assessment to contribute to more effective and expedited patient treatment. • Recognize toxicities and optimize the management of class-specific side effects of bladder cancer therapies. • Analyze the current available treatment approaches including systemic and novel treatments, in non-muscle invasive bladder cancer. • Discuss the role of immunotherapy in the treatment of bladder and kidney cancers. • Identify common immune related adverse effects and their management based on current guidelines and evidence.

2019 Comprehensive Stroke Symposium is organized by MedStar Health and will be held from May 03 - 04, 2019 at Bethesda, Maryland, United States of America. The target audience for this medical event is Critical Care, Emergency Medicine, Family Medicine, Internal Medicine, Neurology, Neurosurgery, Surgery. Additional details will be posted as soon as they are available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on May 17, 2019 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

National Advisory Dental & Craniofacial Research Council Meeting is organized by National Institute of Dental and Craniofacial Research (NIDCR) and will be held on May 23, 2019 at National Institutes of Health, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

North American Primary Care Research Group (NAPCRG) Practice-based Research Network (PBRN) Conference is organized by North American Primary Care Research Group (NAPCRG) and would be held during Jun 24 - 25, 2019 at Hyatt Regency Bethesda, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Sep 13, 2019 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Jan 31, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on May 29, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Sep 11, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.